Alector (ALEC) Equity Average (2018 - 2026)
Alector (ALEC) reported Equity Average of $20.5 million for Q1 2026, down 81.47% year-over-year from $110.7 million in Q1 2025, and down 53.56% quarter-over-quarter from $44.2 million in Q4 2025.
Alector (ALEC) Equity Average (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Equity Average data on file, last reported at $20.5 million in Q1 2026.
- Equity Average for Q1 2026 came in at $20.5 million, down 81.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.5 million (down 81.47% YoY), and the FY2025 annual result was $78.7 million, down 39.67% from the prior year.
- Equity Average eased to $20.5 million in Q1 2026 per ALEC's latest filing, from $44.2 million in the prior quarter.
- Over five years, Equity Average peaked at $284.1 million in Q1 2022 and troughed at $20.5 million in Q1 2026.
- A 5-year average of $157.9 million and a median of $156.5 million in 2024 frame the typical range for Equity Average.
- The sharpest annual moves came in 2022 and 2026: Equity Average soared 34.85% in 2022, then slumped 81.47% in 2026.
- A 5-year view of Equity Average shows it stood at $233.8 million in 2022, then plunged by 36.54% to $148.4 million in 2023, then retreated by 17.18% to $122.9 million in 2024, then slumped by 64.04% to $44.2 million in 2025, then plunged by 53.56% to $20.5 million in 2026.
- Business Quant data shows ALEC's Equity Average at $20.5 million in Q1 2026, $44.2 million in Q4 2025, and $64.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | 20.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.52 Mn |
| Dec 31, 2025 | 44.18 Mn |
| Sep 30, 2025 | 64.44 Mn |
| Jun 30, 2025 | 82.89 Mn |
| Mar 31, 2025 | 110.71 Mn |
| Dec 31, 2024 | 122.87 Mn |
| Sep 30, 2024 | 134.75 Mn |
| Jun 30, 2024 | 164.74 Mn |
| Mar 31, 2024 | 156.53 Mn |
| Dec 31, 2023 | 148.36 Mn |
| Sep 30, 2023 | 179.43 Mn |
| Jun 30, 2023 | 189.66 Mn |
| Mar 31, 2023 | 198.73 Mn |
| Dec 31, 2022 | 233.77 Mn |
| Sep 30, 2022 | 270.81 Mn |
| Jun 30, 2022 | 278.03 Mn |
| Mar 31, 2022 | 284.13 Mn |
| Dec 31, 2021 | 318.31 Mn |
| Sep 30, 2021 | 260.20 Mn |
| Jun 30, 2021 | 206.17 Mn |